Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Mature B-cell Neoplasms × ARQ531 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hematologic Neoplasms 2 Mature B-cell Neoplasms 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05673460 2025-09-16

MK-1026-002

Merck Sharp & Dohme LLC

Phase 1 Completed

Mature B-cell Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡